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In most peripheral infections of rodents and sheep with scrapie, infectivity is found first in lymphoid tissues
and later in the central nervous system (CNS). Cells within the germinal centers (GCs) of the spleen and lymph
nodes are important sites of extraneural replication, from which infection is likely to spread to the CNS along
peripheral nerves. Here, using immunodeficient mice, we investigate the identity of the cells in the spleen that
are important for disease propagation. Despite possessing functional T and B lymphocytes, tumor necrosis
factor alpha-deficient (TNF-a2/2) mice lack GCs and follicular dendritic cell (FDC) networks in lymphoid
tissues. In contrast, lymphoid tissues of interleukin-6-deficient (IL-62/2) mice possess FDC networks but have
impaired GCs. When the CNSs of TNF-a2/2, IL-62/2, and wild-type mice were directly challenged with the
ME7 scrapie strain, 100% of the mice were susceptible, developing disease after closely similar incubation
periods. However, when challenged peripherally (intraperitoneally), most TNF-a2/2 mice failed to develop
scrapie up to 503 days postinjection. All wild-type and IL-62/2 mice succumbed to disease approximately 300
days after the peripheral challenge. High levels of scrapie infection and the disease-specific isomer of the prion
protein, PrPSc, were detectable in spleens from challenged wild-type and IL-62/2 mice but not from TNF-a2/2
mice. Histopathological analysis of spleen tissue demonstrated heavy PrP accumulations in direct association
with FDCs in challenged wild-type and IL-62/2 mice. No PrPSc accumulation was detected in spleens from
TNF-a2/2 mice. We conclude that, for the ME7 scrapie strain, mature FDCs are critical for replication in
lymphoid tissues and that in their absence, neuroinvasion following peripheral challenge is impaired.
The transmissible spongiform encephalopathies (TSEs), or
prion diseases, comprise a closely related group of neurode-
generative disorders that include Creutzfeldt-Jakob disease
(CJD) and kuru in humans, scrapie in sheep and goats, trans-
missible mink encephalopathy, and bovine spongiform enceph-
alopathy in cattle. The TSEs are characterized by the deposition
within the brain of PrPSc (4), an abnormal, detergent-insoluble,
relatively protease-resistant isoform of a normal host cellular
protein, PrPc (37). While the precise nature of the agent is still
the subject of controversy (11), PrPSc copurifies with infectivity
(40) and is considered to be a major component of the infec-
tious agent. Furthermore, mice deficient in the PrP gene
(PrP2/2 mice) do not develop TSE disease (7), demonstrating
that host cells must express PrP in order to propagate infec-
tion.
Natural TSE infections are most often acquired by periph-
eral routes of infection. Disease may be established through
the skin (by scarification), orally (through foodstuffs or canni-
balism), or, in some instances of CJD in humans, iatrogenically
through transplantation of CJD-contaminated tissues or pitu-
itary-derived hormones. In the United Kingdom, the consump-
tion of beef products contaminated with bovine spongiform
encephalopathy is the most likely cause of variant CJD (vCJD)
in humans (6).
Following peripheral infection of sheep or rodents with
scrapie, high titers of infectivity rapidly accumulate in the
spleen. Lymphoid tissues play an important role in pathogen-
esis, as genetic asplenia or splenectomy of mice, prior to or
shortly after a peripheral scrapie challenge, significantly ex-
tends the incubation period of the disease (15). From the
lymphoid tissues, infectivity is considered to gain access to the
central nervous system (CNS) via its spread along peripheral
nerves (1, 35). Although it has been suggested that TSE infec-
tion may enter the CNS by hematogenous spread (22), there is
no firm evidence to support this. Once scrapie infection enters
the CNS, the neurodegeneration it causes is irreversible and
death is inevitable.
Thymectomy does not affect the incubation period of the
disease following peripheral challenge (15) and neither does
ionizing irradiation (16), implying that scrapie pathogenesis
depends on radioresistant and mitotically inactive cells. Ioniz-
ing irradiation eliminates T lymphocytes, their precursors, and
actively dividing B lymphocytes as potential sites of scrapie
replication. Follicular dendritic cells (FDCs) fulfil the above
criteria and also decorate strongly with anti-PrP antibodies,
even in uninfected mice (34, 43). In severe combined immu-
nodeficient (SCID) mice, the absence of mature B and T lym-
phocytes prevents the maturation of FDCs (20). These mice
resist peripheral infection with the scrapie strain ME7 (13, 45)
or the human TSE strain Fukuoka-2 (21) and fail to accumu-
late infectivity and PrPSc in their spleens. Maturation of FDCs
and germinal centers (GCs), along with susceptibility to scrapie,
can be induced by grafting SCID mice with bone marrow (13).
As FDC networks do not develop in the absence of lympho-
cytes (20) and both FDCs (5, 34, 43) and lymphocytes (31)
appear to express PrPc, further experiments using mice that
expressed and did not express PrPc in their FDCs and lympho-
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cytes have been undertaken to determine the role of these cells
in scrapie pathogenesis (5).
Signalling between FDCs and lymphocytes through cyto-
kines, including tumor necrosis factor alpha (TNF-a) and in-
terleukin-6 (IL-6), plays an important role in the organization
of the GC. Mice deficient in TNF-a lack splenic primary B-cell
follicles, FDC networks, and GCs (38). Despite the absence of
GC structure, B lymphocytes are still able to respond to anti-
gen stimulation and immunoglobulin class-switching can still
occur. The effects of TNF-a on GC architecture are mediated
via signalling through TNF receptor 1 (TNF-R1) expressed on
FDCs and/or its precursor (46). IL-6 production by FDCs has
also been shown to be important for maintaining GC reactions.
In the lymphoid tissues of mice deficient for IL-6, FDC com-
plexes are able to form but GC development is diminished
(26). To determine if FDCs, GCs, and lymphocytes are re-
quired for susceptibility to a peripherally routed infection,
scrapie pathogenesis was studied in mice which lack FDCs and
GCs but possess functional lymphocytes (TNF-a-deficient
mice) and in mice in which FDC networks are present but GC
development is impaired (IL-6-deficient mice).
MATERIALS AND METHODS
Mice. TNF-a knockout (TNF-a2/2 [38]) and IL-6 knockout (IL-62/2 [25])
mice were bred on a mixed 129/Sv 3 C57BL/6 background. Wild-type (control)
mice also shared the 129/Sv 3 C57BL/6 background.
Scrapie inoculation. Mice were injected intracerebrally (i.c.) or intraperitone-
ally (i.p.) with 20 ml of a 1.0% (wt/vol) dilution of unspun brain homogenate from
C57BL mice terminally affected with scrapie strain ME7. Following challenge,
animals were coded and scored weekly to determine the clinical end point and
incubation period of neurological disease, according to previously established
criteria (14). Scrapie diagnosis was confirmed by histopathological assessment of
vacuolation and PrP immunostaining in the brain. Where indicated, some mice
were sacrificed 5 and 10 weeks postchallenge and spleens were taken for further
analysis. For bioassay of scrapie infectivity, individual spleen halves were pre-
pared as 10% homogenates in physiological saline and injected i.c. into C57BL
assay mice. The scrapie titer in each spleen was determined from the mean
incubation period in the assay mice, by reference to established dose-incubation
period response curves for scrapie-infected spleen tissue.
Immunoblot detection of PrPSc. Tissues were prepared by a modification of a
method previously described (10). Briefly, frozen tissues were weighed and
pulverized in precooled Potter homogenizers and then homogenized in 0.2 M
potassium chloride (2 ml) with 20 ml of each of the protease inhibitors, 100 mM
phenylmethylsulfonyl fluoride (PMSF) and 100 mM N-ethylmaleimide (NEM),
both in propan-1-ol. Suspensions were then centrifuged at 500 3 g for 10 min at
4°C. The supernatants were decanted and centrifuged for 30 min at 100,000 3 g
at 4°C. The resultant pellets were resuspended in 2 ml of 100 mM Tris-HCl at pH
7.4, and the suspension was divided into two equal parts. To one fraction, 20 ml
of 20-mg/ml proteinase K (Sigma, Poole, United Kingdom) was added, and the
contents were incubated at 37°C in an orbital shaker for 60 min; the other
fraction was held at 4°C with 20 ml each of PMSF and NEM (100 mM). Subse-
quently, 1 ml of Sarkosyl (2%, wt/vol), 20 ml each of PMSF and NEM, and 2 ml
of 2-mercaptoethanol were added to all tubes, which were incubated at 37°C for
a further 60 min. The contents of each tube were then layered onto a cushion of
20% sucrose in 50 mM Tris-HCl (pH 7.4) and centrifuged at 100,000 3 g for 2 h
at 4°C. Pellets were drained and stored at 270°C before further analysis.
Samples were then electrophoresed through sodium dodecyl sulfate–12%
polyacrylamide gels and transferred to polyvinylidine difluoride membranes
(Bio-Rad, Hemel Hempstead, United Kingdom) by semidry blotting. Mem-
branes were blocked with 2% bovine serum albumin in 0.1 M Tris-HCl (pH 7.6)
and probed with the PrP-specific rabbit polyclonal antiserum 1B3 (12). Following
counter-staining with alkaline phosphatase-conjugated goat anti-rabbit anti-
serum (Jackson ImmunoResearch Laboratories, Inc., West Grove, Pa.), bound
alkaline phosphatase activity was detected with SigmaFast nitroblue tetrazolium-
BCIP (5-bromo-4-chloro-3-indolylphosphate) solution (Sigma).
Immunohistochemical analysis. Spleens halves were snap-frozen and main-
tained at the temperature of liquid nitrogen. Serial 6-mm-thick sections were cut
on a cryostat, air dried, and fixed in acetone for 10 min. FDCs were visualized by
staining first with FDC-M1 monoclonal antiserum (28) and subsequently with
biotinylated murine anti-rat serum. To detect PrP, sections were stained first with
1B3 polyclonal antiserum and subsequently with biotinylated goat anti-rabbit
serum (Jackson ImmunoResearch Laboratories). To visualize GC B cells, sec-
tions were stained with biotinylated peanut agglutinin (Vector Laboratories,
Peterborough, United Kingdom). Immunolabeling was carried out using alkaline
phosphatase coupled to the avidin-biotin complex (Vector Laboratories). Vector
Red (Vector Laboratories) was used as a substrate.
For the detection of PrP in brain tissue, brains were fixed in periodate-lysine-
paraformaldehyde and embedded in paraffin wax. Sections (thickness, 6 mm)
were deparaffinized, and pretreated to enhance PrP immunostaining by hydrated
autoclaving (15 min, 121°C, hydration), and subsequent immersion in formic acid
(98%) for 5 min (34). Sections were then stained with the PrP-specific antiserum
1B3 or normal rabbit serum as a control and immunocytochemical labeling was
carried out using the peroxidase-antiperoxidase technique with diaminobenzi-
dine as a substrate. Sections were counterstained with hematoxylin to distinguish
cell nuclei.
Immunohistoblot analysis of PrPSc. Spleen halves were snap-frozen and main-
tained at the temperature of liquid nitrogen. Serial 10-mm-thick sections were cut
on a cryostat, applied directly to polyvinylidine difluoride membranes, and thor-
oughly air dried. For the detection of total PrP (PrPc and PrPSc) and PrPSc alone,
membranes were rehydrated and treated in the absence and presence (respec-
tively) of 20 mg of proteinase K per ml for 60 min at 37°C, as previously described
(44). Following processing, membranes were probed with PrP-specific polyclonal
antiserum 1B3 and counter-stained with alkaline phosphatase-conjugated goat
anti-rabbit antiserum and bound alkaline phosphatase activity was detected with
SigmaFast nitroblue tetrazolium-BCIP solution.
RESULTS
Susceptibility of TNF-a2/2 and IL-62/2 mice to scrapie
infection. When mice were challenged i.c. with scrapie strain
ME7, no significant differences between wild-type, TNF-a2/2,
and IL-62/2 mice in the onset of clinical signs or incubation
period of disease were observed (Fig. 1). All i.c. infected mice
succumbed to disease approximately 170 days postchallenge.
Histopathologic analysis of brain tissue from terminal i.c. in-
fected wild-type, IL-62/2, and TNF-a2/2 mice showed the
characteristic spongiform pathology and PrPSc accumulation
associated with ME7. Thus, if scrapie was delivered directly to
the CNS, scrapie pathogenesis in the brain proceeded without
any detectable influence of the immune status of the host.
When mice were challenged with scrapie peripherally via the
i.p. route, no significant difference was observed between wild-
type and IL-62/2 mice in the incidence and incubation period
of disease. With both of these mouse strains, all animals suc-
cumbed to infection following mean incubation periods of
303 6 4 days (wild-type mice; n 5 8) and 309 6 4 days (IL-62/2
mice; n 5 14) (Fig. 1). Furthermore, spongiform pathology,
gliosis, and PrPSc accumulation typical of an i.p. infection with
scrapie strain ME7 were detected in the brains of wild-type and
IL-62/2 i.p. challenged mice (Fig. 2a and b, respectively). In
contrast, following i.p. challenge of TNF-a2/2 mice with
scrapie, five of eight mice remained free of signs of disease up
to 503 days postinfection, at which time the experiment was
terminated (Fig. 1). No evidence of spongiform change or
PrPSc accumulation was detected in the brains of any surviving
i.p. challenged TNF-a2/2 mice (Fig. 2c). However, three of
eight TNF-a2/2 mice did succumb to an i.p. challenge with
scrapie. In these, disease developed after individual incubation
periods of 350, 441, and 475 days. These incubations periods
FIG. 1. Incubation period of disease following i.c. or i.p. challenge of wild-
type (WT), IL-62/2, and TNF-a2/2 (TNF2/2) mice with scrapie strain ME7.
Each bar represents the mean 6 the standard error for 5 to 14 mice. While most
i.p. challenged TNF-a2/2 mice remained free of the clinical signs of scrapie 503
days postinfection, three mice did succumb to disease (dots).
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were beyond the range seen in i.p. infected wild-type and
IL-62/2 mice (289 to 325 and 280 to 325 days, respectively).
Scrapie infectivity and PrPSc accumulation in the spleen.
High levels of scrapie infectivity were detected in spleens from
wild-type mice collected 35, 70, and 310 days postchallenge, by
which time the mice were terminally affected with scrapie (Ta-
ble 1). Interestingly, no infectivity has been detected so far in
one of four spleens collected 35 days postchallenge, suggesting
a titer less than 2.5-log-unit i.c. 50% infective doses (ID50)/g.
However, by 70 days postchallenge, high levels of infection
were detected in all four spleens assayed. In contrast, scrapie
infectivity has so far been undetectable in all of the spleens
taken from scrapie-challenged TNF-a2/2 mice 35, 70, and 503
days postchallenge (Table 1). While most indicator mice in-
jected with tissue from infected-wild-type mice succumbed to
TSE disease between 175 and 210 days postchallenge, all those
injected with tissue from challenged TNF-a2/2 mice remained
free of TSE disease up to at least 400 days postchallenge. This
represents an infectious titer, if present, below 2.0-log-unit i.c.
ID50/g (the limit of detection of the assay), at least 1,000-fold
less than the titer measured in spleens from wild-type mice.
High levels of scrapie infectivity were detected in all spleens
collected from IL-62/2 mice 35 and 70 days postchallenge
(Table 1).
Immunoblot analysis of tissue from i.p. challenged, termi-
nally scrapie-affected wild-type and IL-62/2 mice detected
large accumulations of detergent-insoluble, proteinase K-resis-
tant PrPSc in the spleen (Fig. 3a). In contrast, no PrPSc was
detected in spleens derived from i.p. challenged TNF-a2/2
mice, which remained free of the signs of scrapie 503 days
postinfection (Fig. 3a), or from any of the three TNF-a2/2
mice that succumbed to disease (Fig. 3b).
Large FDC networks and peanut agglutinin-positive GCs
were detected by immunohistochemistry in the spleens of wild-
type mice (Fig. 4a and d, respectively). In spleens from IL-62/2
mice, FDC networks were detected but GCs were impaired
and considerably smaller than those from wild-type mice (Fig.
4b and e, respectively). Neither mature FDCs nor GCs were
detected in tissues from TNF-a2/2 mice (Fig. 4c and f, respec-
tively). Analysis of adjacent sections of spleen from both wild-
type and IL-62/2 mice demonstrated large PrP accumulations
(Fig. 4j and k, respectively) in direct association with FDCs
(Fig. 4g and h, respectively) in tissue taken 10 weeks post-
peripheral challenge with scrapie. No FDCs or PrP accumula-
tions were detected immunocytochemically in the spleens of
TNF-a2/2 mice (Fig. 4i and l, respectively). Further analysis of
adjacent cryostat sections by immunohistoblotting demon-
strated that in spleens from scrapie-challenged wild-type mice,
large proteinase K-resistant PrPSc accumulations (Fig. 5g) oc-
curred in direct association with FDCs (Fig. 5a). No PrPSc
accumulations or FDCs were detected in spleens from scrapie-
challenged TNF-a2/2 mice (Fig. 5b and h, respectively). In
spleens from uninfected wild-type mice, only the proteinase
K-sensitive, cellular isomer of the prion protein, PrPc, was
detected in association with FDCs (Fig. 5f, i, and c, respective-
ly). Taken together, these observations demonstrate that fol-
lowing peripheral challenge with scrapie strain ME7, PrPSc
accumulates in the spleen in direct association with FDCs.
Interestingly, no PrPc was detectable by immunoblot analysis
in spleens derived from TNF-a2/2 mice (Fig. 3), although low
levels were detected in spleens from uninfected wild-type an-
imals by immunoblot analysis (data not shown) and immuno-
histoblot analysis (Fig. 5f). This difference is most likely due to
the lack of FDCs expressing high levels of PrPc in the spleens
of TNF-a2/2 mice.
DISCUSSION
The susceptibility of TNF-a2/2 mice to peripheral challenge
with scrapie in this study was greatly reduced in comparison
with that of immunocompetent wild-type mice. We also dem-
onstrated that TNF-a2/2 mice, unlike wild-type mice, failed to
accumulate scrapie infectivity in their spleens. However, fol-
lowing peripheral challenge of IL-62/2 mice with scrapie, no
significant differences in incubation period or incidence of
disease were observed between mutant and wild-type mice.
Likewise, high levels of scrapie infectivity were detected in the
FIG. 2. Immunocytochemical analysis of brain tissue from i.p. challenged, terminally scrapie-affected wild-type (a) and IL-62/2 (b) mice detected large PrP
accumulations (brown) in the hippocampus. In contrast, no PrP accumulations were detected in tissue derived from i.p. challenged TNF-a2/2 mice that remained free
of the signs of scrapie 503 days postinfection (c). All sections were counterstained with hematoxylin (blue). Magnification, 3200.
TABLE 1. Scrapie infectivity titers in spleens from wild-type,
IL-62/2, and TNF-a2/2 mice following i.p. challenge
with scrapie strain ME7
Mouse
strain
Levels of scrapie infection in individual mouse spleens
(log i.c. ID50/g) at day postchallengea:
35 70 310b 503c
Wild type 4.4, 4.9, 4.9, UDd 4.7, 4.8, 5.7, 5.8 5.0, 5.7 —e
IL-62/2 4.8, 5.0 5.0, 5.7 — —
TNF-a2/2 UD, UD UD, UD — UD, UD
a At the indicated times postchallenge, scrapie infectivity titers in individual
spleens were determined by i.c. injection of 20 ml of a 10% (wt/vol) spleen
homogenate into groups of 5 to 12 C57BL mice.
b Time at which wild-type mice were clinically affected with scrapie.
c Brains from the individual TNF-a2/2 mice assayed were free of the signs of
scrapie at this time postchallenge.
d UD, scrapie infection undetectable. All recipient mice remained free of the
signs of TSE disease at least 400 days postinjection, indicating a titer of ,2.0
log-unit i.c. ID50/g.
e —, not done.
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spleens of challenged IL-62/2 mice. The disease-specific iso-
mer of the prion protein, PrPSc, is associated with high levels of
scrapie infectivity (40) and provides a reliable indicator for the
presence of infection in this model (10). Large PrPSc accumu-
lations were detected in the spleens of scrapie-challenged wild-
type and IL-62/2 mice but not in the spleens of TNF-a2/2
mice. This was true even for the few TNF-a2/2 mice that
developed disease after protracted incubation periods.
Overexpression of TNF-a has been implicated as a key
pathogenic mediator in several human inflammatory, infec-
tious, and autoimmune CNS disorders (39), including bacterial
meningitis (30), multiple sclerosis (42), cerebral malaria (17),
and Alzheimer’s disease (36). In rodents, neutralization of
TNF-a prevents the formation of inflammatory lesions and
demyelination caused by experimental autoimmune encepha-
lomyelitis (24). Induction of IL-1a, IL-1b, IL-6, and TNF-a
synthesis has been reported to occur in the brains of mice
showing clinical signs of scrapie (47), suggesting that cytokines
may be significant factors in determining the pathogenesis of
neurodegeneration in scrapie. Similarly, expression of TNF-a
and IL-1a is increased in the brains of mice infected experi-
mentally with the Fujisaki strain of human TSE (27). Here,
when the CNSs of TNF-a2/2 and IL-62/2 mice were infected
directly with scrapie, no significant differences were observed
between mutant and wild-type mice in either the onset of
clinical disease or CNS pathology. Although cytokine produc-
tion by activated glia precedes the apoptotic loss of hippocam-
pal neurons in brains from scrapie-infected mice (47), the
experiments presented here suggest that TNF-a and IL-6
alone do not play a critical role in the development of pathol-
ogy in the CNS. Therefore, the apparent resistance of TNF-
a2/2 mice to i.p. challenge with scrapie could not be attributed
to a role of TNF-a in the development of pathology in the
CNS. Our experiments strongly suggest that the effects of
TNF-a operate at a peripheral stage, prior to neuroinvasion.
How scrapie infectivity is delivered to the lymphoid tissues is
not known. As membrane lymphotoxin, instead of TNF-a,
regulates the migration of dendritic cells in the spleen (48), it
is unlikely that the effects of TNF-a deficiency on scrapie
pathogenesis are due to impaired cell trafficking from the site
of scrapie challenge to the spleen. Gene deletion experiments
with mice have shown that signalling by both TNF-a and lym-
photoxin a/b is required for FDC development (33, 38). The
subsequent maintenance of FDCs in a differentiated state re-
quires the continual stimulation of FDCs by B lymphocytes
through lymphotoxin a/b and TNF-a (32). Hence, lymphoid
tissues from TNF-a2/2 mice lack FDC networks and GCs but
possess functional lymphocytes (38). In contrast, recent work
suggests that IL-6 production by FDCs may act directly on GC
B lymphocytes via IL-6-sensitive transcription factors and may
also amplify local C3 synthesis by tingible body macrophages
(25). This leads to impaired GC formation and antibody re-
sponses, but mice deficient in the production of IL-6 are able
to form FDC complexes. Our experiments suggest that defi-
ciencies in GCs alone do not affect scrapie pathogenesis, as
peripherally challenged IL-62/2 mice developed disease at the
same time as wild-type mice and had high levels of scrapie
infectivity and large PrPSc accumulations in their spleens. It is
also unlikely that T and B lymphocytes are directly involved in
disease pathogenesis, as these cells are present and functional
in lymphoid tissues of TNF-a2/2 mice (38), which did not
develop disease or accumulate scrapie infectivity or PrPSc in
the spleen. Immunohistopathology demonstrated that the
large PrPSc accumulations in the spleens of wild-type and IL-
62/2 mice were directly associated with FDCs. FDCs were
completely absent in spleens from challenged TNF-a2/2 mice.
We therefore conclude that scrapie accumulation in the spleen
depends on the presence of mature FDCs. These findings are
consistent with recent experiments that used mice that ex-
pressed and mice that did not express PrPc in their FDCs and
lymphocytes. In these experiments, replication of scrapie strain
ME7 in the spleen was also dependent on PrPc-expressing
FDCs (5). From the spleen, infectivity is most likely to spread
to the CNS along peripheral nerves (1, 34), as noradrenergic
and peptidergic nerve fibers are present in both primary and
secondary lymphoid organs among cells of the lymphoid folli-
cles (2).
FIG. 3. Immunoblot analysis of spleen tissue from wild-type (WT), TNF-
a2/2, and IL-62/2 mice following intraperitoneal challenge with the ME7
scrapie strain. Samples were treated in the presence (1) or absence (2) of
proteinase K (PK) before electrophoresis. (a) Large PK-resistant accumulations
of PrPSc were detected in spleens derived from clinically scrapie-affected WT and
IL-62/2 mice. No PrPSc accumulations were detected in spleens derived from
scrapie-challenged TNF-a2/2 mice that remained free of disease 503 days
postinfection. (b) Large PK-resistant accumulations of PrPSc were detected in
spleens derived from clinically scrapie-affected WT mice but not in spleens
derived from clinically affected TNF-a2/2 mice. Values given below lanes are the
individual incubation periods of disease or times postchallenge at which the
spleens were harvested. Lane M, molecular size markers.
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Interestingly, three TNF-a2/2 mice did succumb to scrapie
following peripheral challenge, although with significantly
longer incubation periods than challenged wild-type and IL-
62/2 mice. No PrPSc was detected in the spleens of any clini-
cally scrapie-positive TNF-a2/2 mice, suggesting that due to a
lack of FDCs, spleen tissue is not involved in pathogenesis.
Similarly, while SCID mice resist peripheral challenge with
moderate doses of scrapie strain ME7, high doses produce
CNS disease despite only trace levels of infection in the spleen
(13). How scrapie infection had spread to the CNS in both of
these instances is not known. Klein and colleagues (22) sug-
gested that peripheral blood lymphocytes may carry infection
from the periphery to the CNS. However, subsequent experi-
ments have failed to detect infectivity in peripheral blood lym-
phocytes, despite high levels of infectivity in the spleen in this
model (41). The most likely explanation is that in the absence
of a functional immune system, neurological disease follows
direct uptake of infection by nerve endings in the periphery
and spreads to the CNS along peripheral nerves (1).
The pathogenesis of scrapie strain ME7 following peripheral
challenge appears to differ significantly from that of the scrapie
isolate RML studied elsewhere; in that study infection accu-
mulated in the spleen in the absence of PrPc expression on
FDCs (3). Further experiments using the RML scrapie isolate
implicated B lymphocytes in disease pathogenesis, as mice
deficient in B lymphocytes failed to accumulate infectivity in
their spleens and were refractory to disease (22). However, as
outlined above, mice deficient in B lymphocytes are also indi-
rectly deficient in FDCs, as lymphocytes provide important
signals for their maturation and maintenance (20, 32, 33). In
order to distinguish between these two cell populations in the
pathogenesis of the RML scrapie isolate, TNF-R12/2 mice
FIG. 4. Immunocytochemical analysis of GC structure and PrP accumulation in spleen tissue from ME7-challenged mice. (a to c) Sections from wild-type (a),
IL-62/2 (b), and TNF-a2/2 (c) mice were stained with FDC-M1 antiserum to detect FDCs (red). (d to f) Adjacent sections from wild-type (d), IL-62/2 (e), and
TNF-a2/2 (f) mice were stained with peanut agglutinin to detect GCs (red). (g to i) Sections from wild-type (g), IL-62/2 (h), and TNF-a2/2 (i) mice were stained with
FDC-M1 (red). (j to l) Adjacent sections from wild-type (j), IL-62/2 (k), and TNF-a2/2 (l) mice were stained with the PrP-specific antiserum 1B3 (red). Magnification,
3100 (a to f) and 3400 (g to l).
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were used. Like TNF-a2/2 mice, these mice lack mature FDCs
but do possess functional lymphocytes (29, 33). Interestingly,
TNF-R12/2 mice were as susceptible to peripheral challenge
with the RML scrapie isolate as wild-type mice (22), implying
that in the presence of PrP-expressing lymphocytes, FDCs are
not critical for the pathogenesis of RML. In a third study, PrP
expression on B lymphocytes was not critical for RML patho-
genesis (23) in the presence of PrP-expressing FDCs. These
observations suggest that the RML scrapie isolate, unlike the
ME7 scrapie isolate, may utilize both FDCs and B lympho-
cytes, but the exact roles of these two cell types are not clear.
However, direct comparisons of the peripheral pathogenesis of
the RML scrapie isolate and the ME7 scrapie strain are re-
quired to demonstrate that the discrepancy between them is
not due to different experimental practices.
The apparent differences in the pathogenesis of the ME7
and RML scrapie isolates have important implications, as they
suggest that different scrapie strains may target different cell
populations in lymphoid tissues. Current evidence suggests a
similar variation in human TSE diseases, as PrPSc is detected in
non-CNS tissues, including lymph nodes, tonsils (18), and ap-
pendix (19), from patients with vCJD but not from patients
with sporadic or even iatrogenic CJD, where infection is intro-
duced via the periphery. The risk of horizontal infection
through transfusion and transplantation of vCJD-contami-
nated tissue or use of contaminated surgical instruments is a
matter of urgent concern, particularly given the fact that in-
traspecies transmissions usually increase the risk of infection.
Once TSEs spread to the CNS, the neurodegeneration they
cause is most likely irreversible. Treatments that interfere with
the early stages of infection in peripheral tissues can signifi-
cantly decrease scrapie susceptibility (8, 9). Therefore, the
identification of FDCs as critical cells in the peripheral patho-
genesis of TSE diseases is fundamental for determining the
risk of iatrogenic spread and the development of practical
prophylactic and therapeutic strategies.
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FIG. 5. Immunohistoblot analysis of PrP accumulation in the spleen. (a to c) Sections from scrapie-challenged wild-type (WT) (a), scrapie-challenged TNF-a2/2
(b), and uninfected wild-type (c) mice were stained with FDC-M1 antiserum to detect FDCs (red). (d to i) Histoblots were prepared from adjacent sections for specific
staining of total PrP-PrPc and PrPSc. (d to f) Immunodetection of total PrP-PrPc in samples from scrapie-challenged wild-type (d), scrapie-challenged TNF-a2/2 (e),
and uninfected wild-type (f) mice without prior treatment with proteinase K (2PK). (g to i) Immunodetection of PrPSc in samples from scrapie-challenged wild-type
(g), scrapie-challenged TNF-a2/2 (h), and uninfected wild-type (i) mice with prior treatment with proteinase K (1PK). Following treatment, histoblots were stained
with the PrP-specific antiserum 1B3. Magnification, 340.
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